77 related articles for article (PubMed ID: 19376117)
1. HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation.
Yang J; Hong Y; Wang W; Wu W; Chi Y; Zong H; Kong X; Wei Y; Yun X; Cheng C; Chen K; Gu J
FEBS Lett; 2009 May; 583(9):1409-14. PubMed ID: 19376117
[TBL] [Abstract][Full Text] [Related]
2. GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.
Chou CH; Chou AK; Lin CC; Chen WJ; Wei CC; Yang MC; Hsu CM; Lung FW; Loh JK; Howng SL; Hong YR
Cell Cycle; 2012 Feb; 11(3):532-42. PubMed ID: 22262180
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.
Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM
Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells.
Hong Y; Yang J; Wu W; Wang W; Kong X; Wang Y; Yun X; Zong H; Wei Y; Zhang S; Gu J
Biochim Biophys Acta; 2008 Nov; 1782(11):649-57. PubMed ID: 18930135
[TBL] [Abstract][Full Text] [Related]
5. BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells.
Hong Y; Yang J; Chi Y; Wang W; Wu W; Yun X; Kong X; Gu J
Mol Cell Biochem; 2010 Jan; 333(1-2):323-30. PubMed ID: 19763795
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M
Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein.
Kim JH; Sohn SY; Benedict Yen TS; Ahn BY
Biochem Biophys Res Commun; 2008 Feb; 366(4):1036-42. PubMed ID: 18155658
[TBL] [Abstract][Full Text] [Related]
8. HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome.
Westhoff B; Chapple JP; van der Spuy J; Höhfeld J; Cheetham ME
Curr Biol; 2005 Jun; 15(11):1058-64. PubMed ID: 15936278
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment.
Tait SW; de Vries E; Maas C; Keller AM; D'Santos CS; Borst J
J Cell Biol; 2007 Dec; 179(7):1453-66. PubMed ID: 18166654
[TBL] [Abstract][Full Text] [Related]
10. CREB activates proteasomal degradation of DSCR1/RCAN1.
Seo SR; Chung KC
FEBS Lett; 2008 Jun; 582(13):1889-93. PubMed ID: 18485898
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target.
Shabek N; Iwai K; Ciechanover A
Biochem Biophys Res Commun; 2007 Nov; 363(2):425-31. PubMed ID: 17870054
[TBL] [Abstract][Full Text] [Related]
12. Proteasome degradation of protein C and plasmin inhibitor mutants.
Nishio M; Koyama T; Nakahara M; Egawa N; Hirosawa S
Thromb Haemost; 2008 Sep; 100(3):405-12. PubMed ID: 18766255
[TBL] [Abstract][Full Text] [Related]
13. TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination.
Kim SA; Chang S; Yoon JH; Ahn SG
FEBS Lett; 2008 Mar; 582(5):734-40. PubMed ID: 18258197
[TBL] [Abstract][Full Text] [Related]
14. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
15. Two wobble-splicing events affect ING4 protein subnuclear localization and degradation.
Tsai KW; Tseng HC; Lin WC
Exp Cell Res; 2008 Oct; 314(17):3130-41. PubMed ID: 18775696
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system.
Sadeh R; Breitschopf K; Bercovich B; Zoabi M; Kravtsova-Ivantsiv Y; Kornitzer D; Schwartz A; Ciechanover A
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15690-5. PubMed ID: 18836078
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.
Adamopoulos PG; Kontos CK; Tsiakanikas P; Scorilas A
Cancer Lett; 2016 Apr; 373(1):119-129. PubMed ID: 26797417
[TBL] [Abstract][Full Text] [Related]
18. Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway.
Uekusa H; Namimatsu M; Hiwatashi Y; Akimoto T; Nishida T; Takahashi S; Takahashi Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):673-8. PubMed ID: 19285020
[TBL] [Abstract][Full Text] [Related]
19. A dominant vimentin mutant upregulates Hsp70 and the activity of the ubiquitin-proteasome system, and causes posterior cataracts in transgenic mice.
Bornheim R; Müller M; Reuter U; Herrmann H; Büssow H; Magin TM
J Cell Sci; 2008 Nov; 121(Pt 22):3737-46. PubMed ID: 18940912
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation.
Dantuma NP; Heinen C; Hoogstraten D
DNA Repair (Amst); 2009 Apr; 8(4):449-60. PubMed ID: 19223247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
